GRIMAUD BRETT A. (SVP, GEN COUNSEL AND SECRETARY) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/24/2025ACC: 0001966698-25-000006
Officer· SVP, GEN COUNSEL AND SECRETARY
Since Feb 2026
-19.02K
Net shares
Net seller
$340.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
19.02K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−19.02K
Price / share
$17.90
Trade value
$340.53K
% of position
5.1%
11/20/2025
374.31K→355.28K
Total
Net shares
−19.02K
Net value
-$340.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/20/2025 | F · Tax Withholding | −19.02K | $17.90 | $340.53K | 5.1% | 374.31K | 355.28K |
| Total | −19.02K | -$340.53K | ||||||
Derivative Transactions0
No derivative transactions reported